Get Started for FREE
Sign up with Facebook Sign up with X
I don't have a Facebook or a X account
 Your new post is loading...
Your new post is loading...
Scoop.it!
HACKENSACK, N.J. and PETACH TIKVAH, Israel, Feb. 6, 2017 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced today that Chaim Lebovits, Chief Executive Officer, will provide a corporate overview at BIO CEO & Investor Conference, being held on February 13-14, 2017 at the Waldorf Astoria in New York City. 
No comment yet.
Sign up to comment
Scoop.it!
Detroit Red Wings legend Gordie Howe has made such a dramatic recovery after having stem cell therapy in December in Tijuana, Mexico, that he's heading to Saskatchewan this weekend for a fund-raiser.
Scoop.it!
It’s harder for members of minority groups get the right genetic match; cultural factors add to the difficulty.
Scoop.it!
BrainStorm Cell Therapeutics (otcqb:BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today announced that the European Commission has granted Orphan Drug Designation for NurOwn(TM), the Company's stem cell therapy consisting of autologous bone marrow-derived mesenchymal stromal cells secreting neurotrophic factors, for the treatment of Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig's Disease. NurOwn received Orphan Drug Designation from the............
Scoop.it!
BrainStorm Cell Therapeutics said the Mayo Clinic in Minnesota has agreed to conduct a clinical trial of the company's adult stem cell treatment for ALS. The Mayo Clinic is the third leading U.S. clinical site to sign a letter of understanding, following the University of Massachusetts and Massachusetts General, BrainStorm said
Scoop.it!
BrainStorm Cell Therapeutics , a leading developer of
adult stem cell technologies for neurodegenerative diseases, announced today that it has signed an agreement with Octane. BrainStorm is currently conducting a Phase I/II clinical trial in ALS patients at the Hadassah Medical Center in Jerusalem and is planning to expand its clinical development in the USA, pending FDA approval. Towards that goal, the Company has entered into a Memorandum of Understanding with the University of Massachusetts Medical School and Massachusetts General Hospital to begin ALS human clinical trials at these institutions.
Scoop.it!
MOBILE, Alabama, Baldwin County doctor that treated former Alabama football players with adult stem cells also has treated at least two people diagnosed with amyotrophic lateral sclerosis, also known as Lou Gehrigs disease.
|
Scoop.it!
Biotech Lonza announces an IPS cell manufacturing process for human therapy. The basic technology is available free of charge, and customers can also pay Lonza to provide the service.
Scoop.it!
Alright, another week post surgery and I’m feeling so much better than last week’s post. I have much more range of motion in my neck. Even if I do something that aggravates it, the pain is much les...
Scoop.it!
This clinical trial will test the safety of increasing doses of stem cells injected into the spinal cord of patients with ALS. There will be 15 - 18 patients in the study, separated into 5 dosing groups, A-E, with 3 patients in each group. The first 4 groups will receive injections into the cervical spinal cord in the neck, into the region that controls the breathing muscles. The subjects will receive either 5 (group A) or 10 (group B-E) injections on both sides of the spinal cord, for a total of either 10 or 20 injections. The number of cells will increase with each dosing group from 2 million to 8 million cells injected. Group E subjects will undergo two surgeries, first injections into the lumbar cord (lower spine) followed several weeks later by injections into the cervical spinal cord. Eligible participants must all be able to....................
Scoop.it!
Researchers at the University of Wisconsin-Madison have accomplished a notable feat in stem cell research that could lead to new models for drug screening and discovery--they have transformed human embryonic stem cells into nerve cells that helped mice regain the ability to learn and remember. In what the UW scientists believe is the first study of its kind, a.............
Scoop.it!
Neuralstem is developing neural stem cell therapy and pharmaceuticals for the treatment of diseases and conditions of the CNS, including ALS, chronic spinal cord injury, chronic stroke, major depression…...
Scoop.it!
Neuralstem, Inc. (NYSE MKT: CUR) announced that Jonathon Glass, MD, Director of the Emory ALS Center, presented new data from the Phase I trial of Neuralstem's human spinal cord stem cells, NSI-566, in amyotrophic lateral sclerosis...
Scoop.it!
BrainStorm Cell Therapeutics Inc. a
|
